Combined lentiviral- and RNA-mediated CRISPR/Cas9 delivery for efficient and traceable gene editing in human hematopoietic stem and progenitor cells
Abstract The CRISPR/Cas9 system is a versatile tool for functional genomics and forward genetic screens in mammalian cells. However, it has been challenging to deliver the CRISPR components to sensitive cell types, such as primary human hematopoietic stem and progenitor cells (HSPCs), partly due to...
Enregistré dans:
Auteurs principaux: | David Yudovich, Alexandra Bäckström, Ludwig Schmiderer, Kristijonas Žemaitis, Agatheeswaran Subramaniam, Jonas Larsson |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/37fcffdd00f84de08d81d45c0b3fdfd6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Functional profiling of single CRISPR/Cas9-edited human long-term hematopoietic stem cells
par: Elvin Wagenblast, et autres
Publié: (2019) -
CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells
par: J. Boutin, et autres
Publié: (2021) -
Multiplex CRISPR/Cas9 genome editing in hematopoietic stem cells for fetal hemoglobin reinduction generates chromosomal translocations
par: Clare Samuelson, et autres
Publié: (2021) -
Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing
par: Asmamaw M, et autres
Publié: (2021) -
Engineering of CRISPR-Cas12b for human genome editing
par: Jonathan Strecker, et autres
Publié: (2019)